期刊文献+
共找到13篇文章
< 1 >
每页显示 20 50 100
Facile Conversion of Alcohols to Olefins by Tosylation and Subsequent SiO_2-promoted β-elimination
1
作者 RUAN Xiaohong SONG Gaopeng ZHANG Yichun LI Yingxia 《Journal of Ocean University of China》 SCIE CAS 2007年第2期196-198,共3页
A convenient and effective procedure was developed for the conversion of alcohol to olefin by tosylation and subsequent β-elimination promoted by silica gel in this study. Treatment of the alcohols with p-toluenesulf... A convenient and effective procedure was developed for the conversion of alcohol to olefin by tosylation and subsequent β-elimination promoted by silica gel in this study. Treatment of the alcohols with p-toluenesulfonyl chloride in pyridine at 0℃ af- fords tosylates which undergo β-elimination with silica gel in dichloromethane or chloroform at room temperature, yielding olefins with high productivity. 展开更多
关键词 alcohol tosylation silica gel OLEFIN β-elimination
在线阅读 下载PDF
治疗精神分裂症新药--对甲苯磺酸芦玛哌酮(lumateperone tosylate) 被引量:5
2
作者 陈本川 《医药导报》 CAS 北大核心 2020年第8期1170-1178,I0001,共10页
精神分裂症是一组病因未明、复杂而严重的精神障碍性疾病,影响全球2.1亿人,起病于青少年晚期及成年早期,其结局不容乐观。精神分裂症患者的症状分为两种类型,阳性症状(如躁狂、易怒等)较容易控制,而阴性症状(如冷漠、意志贫乏等)较难改... 精神分裂症是一组病因未明、复杂而严重的精神障碍性疾病,影响全球2.1亿人,起病于青少年晚期及成年早期,其结局不容乐观。精神分裂症患者的症状分为两种类型,阳性症状(如躁狂、易怒等)较容易控制,而阴性症状(如冷漠、意志贫乏等)较难改善,目前仍然是一种难以治愈的终身性疾病。至少1/3的精神分裂症患者对现有治疗药物无应答,多数患者在治疗18个月后,因严重不良反应(如体质量增加、运动障碍等)而终止治疗。治疗精神分裂症新药的开发非常困难,临床失败信息居多,绝大多数厂家都已放弃。治疗精神分裂症新药对甲苯磺酸芦玛哌酮(lumateperone tosylate)由美国百时美施贵宝制药公司(Bristol-Myers Squibb,BMS)首先研制,2015年美国Intra-Cellular Therapies(ICT)生物制药公司获得BMS公司许可,进行全球开发。有效成分芦玛哌酮具有中枢神经系统(CNS)5-羟色胺5-HT 2A受体拮抗药的活性,与CNS多巴胺D2受体的突触后拮抗药组合作用,介导谷氨酸信号通道对精神分裂症患者受损起重要作用。芦玛哌酮能通过抑制5-羟色胺转运体蛋白(SERT)调节5-羟色胺,并作为5-HT 2A受体拮抗药发挥作用,用于治疗精神分裂症及其他神经系统疾病的行为障碍。2018年9月美国ICT公司向美国食品药品监督管理局(FDA)递交对甲苯磺酸芦玛哌酮胶囊用于治疗精神分裂症的新药上市申请,FDA曾于2017年11月授予快速通道地位,并于2019年12月20日批准上市,商品名为Caplyta。该文对对甲苯磺酸芦玛哌酮胶囊的非临床和临床药理毒理学、临床研究、不良反应、适应证、剂量与用法、用药注意事项及知识产权状态和国内外研究进展等进行介绍。 展开更多
关键词 甲苯磺酸芦玛哌酮 Lumateperone tosylate 精神分裂症 5-羟色胺5-HT 2A受体 拮抗药
暂未订购
抗菌新药硫酸头孢地尔对甲苯磺酸盐(cefiderocol sulfate tosylate) 被引量:4
3
作者 陈本川 《医药导报》 CAS 北大核心 2020年第7期1026-1034,I0001,共10页
抗微生物耐药性(AMR)泛指细菌、病毒、真菌等病原体感染不被抗菌药物及其他抗感染药物有效抑制或杀灭的抵御能力。近几年,这一概念逐渐取代了抗菌药耐药性(ABR),全面涵盖大部分传染性疾病的耐药性,为国际卫生研究组织所采用。AMR是一项... 抗微生物耐药性(AMR)泛指细菌、病毒、真菌等病原体感染不被抗菌药物及其他抗感染药物有效抑制或杀灭的抵御能力。近几年,这一概念逐渐取代了抗菌药耐药性(ABR),全面涵盖大部分传染性疾病的耐药性,为国际卫生研究组织所采用。AMR是一项急需解决的严重社会问题,仅在美国和欧洲,每年即各有5万~6万人死于AMR感染。若不采取有效措施,到2050年,全球每年将有一千万人死于抗微生物耐药感染性疾病,经济负担将超过100万亿美元,研制新型抗耐药性药物势在必行。日本盐野义制药株式会社(Shionogi&Co.,Ltd.)独家研制的第5代头孢菌素类抗菌新药--硫酸头孢地尔对甲苯磺酸盐水合物(cefiderocol sulfate tosylate hydrate)应运而生。其有效成分头孢地尔是一种新型铁载体头孢菌素,具有独特的穿透革兰阴性菌细胞膜的作用机制,与三价铁离子络合,通过细菌铁转运蛋白,穿透细胞膜外膜被转运至细菌细胞壁内,使之在细菌胞质中达到更高浓度,与受体结合,抑制细菌细胞壁的生物合成,对所有革兰阴性菌具有强劲的杀灭活性,包括耐碳青霉烯革兰阴性非发酵鲍曼不动杆菌、铜绿假单胞菌、难治性耐碳青霉烯肠杆菌科。头孢地尔开创了用于死亡率很高、且未能满足医疗需求的严重疾病领域。2019年4月2日,盐野义制药株式会社公布了一项头孢地尔治疗复杂性尿路感染(cUTI)II期临床研究的积极结果。该研究达到临床治愈和病原菌根除的主要终点,向美国食品药品管理局(FDA)和欧洲药品管理局(EMA)提出新药上市许可,均被受理。FDA授予头孢地尔合格的抗感染药品(QIDP)资格认定并享受快速通道资格;EMA人用医药产品委员会(CHMP)也授予头孢地尔加速评估资格。2019年10月16日,FDA抗微生物药物咨询委员会投票决定,推荐盐野义制药株式会社的头孢地尔静脉注射液用于治疗高度耐药革兰阴性菌,包括肾盂肾炎在内的cUTI;2019年11月14日,FDA批准头孢地尔静脉注射液上市,商品名Fetroja。该文对头孢地尔静脉注射液的非临床和临床药理毒理学、临床研究、不良反应、适应证、剂量与用法、用药注意事项及知识产权状态和国内外研究进展等进行介绍。 展开更多
关键词 头孢菌素 Cefiderocol sulfate tosylate 头孢地尔对甲苯磺酸盐 尿路感染 复杂性
暂未订购
治疗BRCA突变HER2阴性局部晚期或转移性乳腺癌新药——对甲苯磺酸他佐帕利(talazoparib tosylate) 被引量:3
4
作者 陈本川 《医药导报》 CAS 北大核心 2019年第5期680-686,共7页
Talazoparib tosylate由美国BioMarin制药公司研制,2015年8月Medivation制药公司获得美国BioMarin制药公司在全球开发的授权。2016年8月22日辉瑞制药公司收购Medivation制药公司全部股权,并于2018年6月12日向美国食品药品管理局(FDA)提... Talazoparib tosylate由美国BioMarin制药公司研制,2015年8月Medivation制药公司获得美国BioMarin制药公司在全球开发的授权。2016年8月22日辉瑞制药公司收购Medivation制药公司全部股权,并于2018年6月12日向美国食品药品管理局(FDA)提出talazoparib tosylate新药上市申请。FDA评估了talazoparib tosylate与其他化疗药相比,对胚系(遗传性) BRCA突变(gBRCAm)、HER2阴性局部晚期或转移性乳腺癌(MBC)患者的疗效有突破性进展,授予优先审评资格,于2018年10月16日批准上市,商品名为Talzenna■。欧洲药品管理局(EMA)也接受talazoparib tosylate治疗目标人群的上市申请。该文对Talzenna■的非临床和临床药理毒理学、临床研究、不良反应、适应证、剂量与用法、用药注意事项及知识产权状态和国内外研究进展等进行介绍。 展开更多
关键词 对甲苯磺酸他佐帕利 Talazoparib TOSYLATE 乳腺癌 转移性 BRCA突变 HER2阴性
暂未订购
Omadacycline tosylate (Nuzyra)
5
作者 王美军 董金华 《中国药物化学杂志》 CAS CSCD 北大核心 2019年第4期332-332,共1页
Omadacycline tosylate 是由帕拉泰克制药公司(Paratek Pharmaceuticals,Inc) 研发的新型四环素类抗生素,于 2018 年 10 月 2 日获得美国食品药品管理局(FDA)批准上市,用于治疗社区获得性细菌性肺炎(CABP)和急性细菌性皮肤感染和皮肤结... Omadacycline tosylate 是由帕拉泰克制药公司(Paratek Pharmaceuticals,Inc) 研发的新型四环素类抗生素,于 2018 年 10 月 2 日获得美国食品药品管理局(FDA)批准上市,用于治疗社区获得性细菌性肺炎(CABP)和急性细菌性皮肤感染和皮肤结构感染(ABSSSI)的成人患者。 展开更多
关键词 利奈唑胺 其他药物 二甲基 Omadacycline TOSYLATE Nuzyra
原文传递
Talazoparib tosylate (Talzenna)
6
作者 张冰琦 胡春 《中国药物化学杂志》 CAS CSCD 北大核心 2019年第4期334-334,共1页
最初由 LEAD Therapeutics 研发,后被辉瑞收购的 talazoparib tosylate,于 2018 年 10 月 16 日获美国食品药品管理局(FDA)批准上市,商品名为 Talzenna。该药是一种聚腺苷二磷酸核糖聚合酶 1/2(PARP-1 和 PARP-2)抑制剂,用于治疗 BRCA ... 最初由 LEAD Therapeutics 研发,后被辉瑞收购的 talazoparib tosylate,于 2018 年 10 月 16 日获美国食品药品管理局(FDA)批准上市,商品名为 Talzenna。该药是一种聚腺苷二磷酸核糖聚合酶 1/2(PARP-1 和 PARP-2)抑制剂,用于治疗 BRCA 突变/HER-2 阴性转移性乳腺癌[1]。 展开更多
关键词 乳腺癌患者 抑制剂 Talazoparib TOSYLATE Talzenna
原文传递
Direct N-gem-difluorocyclopropylation of nitro-heterocycles by utilizing gem-difluorocyclopropyl tosylate 被引量:2
7
作者 Wei-Peng Gu Jin-Hong Lin Ji-Chang Xiao 《Chinese Chemical Letters》 SCIE CAS CSCD 2014年第1期24-28,共5页
We have developed an efficient method to achieve N-gem-difluorocyclopropylation of N-heterocycles with the use of gem-difluorocyclopropyl tosylate as a building block under mild conditions, gem- Difluorocyclopropyl to... We have developed an efficient method to achieve N-gem-difluorocyclopropylation of N-heterocycles with the use of gem-difluorocyclopropyl tosylate as a building block under mild conditions, gem- Difluorocyclopropyl tosylates could be easily prepared on a large scale and exhibit great stability. 展开更多
关键词 N-gem-Difluorocyclopropylation N-Heterocycles gem-Difluoracyclopropyl tosylate Building block
原文传递
ORGANIC NONLINEAR OPTICAL CRYSTAL:N-(4-NITROPHENYL)-(s)-(+)-2-PYRROLIDINEMETHYLENE TOSYLATE(NPP-OTs)
8
作者 Cheng YE Nai Jue ZHU Mei Xiang WAN Yan LI (Institute of Chemistry,Academia Sinica,Beijing,100080) 《Chinese Chemical Letters》 SCIE CAS CSCD 1990年第3期241-244,共4页
Large crystal NPP-OTs has been obtained by growth from solution,its powder SHG efficiency is 1/3 of urea.It shows it is a new convenient approach to obtain organic second-order NLO crystal:the dipole-dipole interactio... Large crystal NPP-OTs has been obtained by growth from solution,its powder SHG efficiency is 1/3 of urea.It shows it is a new convenient approach to obtain organic second-order NLO crystal:the dipole-dipole interaction is oppos- ed by introducing a large side group. 展开更多
关键词 NPP-OTs PYRROLIDINEMETHYLENE TOSYLATE ORGANIC NONLINEAR OPTICAL CRYSTAL NITROPHENYL
在线阅读 下载PDF
Improvement on the Synthesis of Primary Amino Sugar Derivatives <i>via</i><i>N</i>-Benzyl Intermediates
9
作者 Massimo Corsi Marco Bonanni +3 位作者 Giorgio Catelani Felicia D’Andrea Tiziana Gragnani Roberto Bianchini 《International Journal of Organic Chemistry》 2013年第3期41-48,共8页
Primary tosylates 1a-d were converted to the corresponding amino species 3a-d. Benzylamine was proved effective for the substitution of tosylates, using acetonitrile (MeCN) as the solvent of choice and citric acid to ... Primary tosylates 1a-d were converted to the corresponding amino species 3a-d. Benzylamine was proved effective for the substitution of tosylates, using acetonitrile (MeCN) as the solvent of choice and citric acid to remove excess of the reagent from crude products 2a-d. Debenzylation was carried out at circa (ca.) atmospheric pressure of hydrogen gas in the presence of acetic acid (AcOH). The method was also demonstrated in a demo batch experiment for the synthesis of compound 3a on a 50 g scale of 1a. 展开更多
关键词 Amino Sugars NUCLEOPHILIC Substitution BENZYLAMINE PRIMARY TOSYLATES
在线阅读 下载PDF
Validated Gradient Stability Indicating UPLC Method for the Determination of Related Substances of Posaconazole in Bulk Drug
10
作者 Vadlamanu Durga Prasad Vanga Ranga Reddy Pasula Aparna 《American Journal of Analytical Chemistry》 2015年第12期965-976,共12页
A stability-indicating UPLC method has been developed and validated for the determination of related substances of Posaconazole with its four related substances (Hydroxytriazole, Tosylated compound, Deshydroxy posacon... A stability-indicating UPLC method has been developed and validated for the determination of related substances of Posaconazole with its four related substances (Hydroxytriazole, Tosylated compound, Deshydroxy posaconazole and Benzylated posaconazole) in the drug substance. Forthwith simple UPLC chromatographic separations were achieved on a Waters Acquity BEH shield C18 (100 mm length, 2.1 mm internal diameter and 1.7 μm particle size) with a mobile phase containing 0.1% Orthophosphoric acid (i.e. 1 mL in 1000 mL water) in gradient combination with acetonitrile (ACN) at a flow rate of 0.5 mL/min and the eluent were monitored at 210 nm. As a result, the resolution of Posaconazole from any of impurities was found to be greater than 2.0. The test solution and spiked solutions were found to be stable in the diluent for 48 h. For the purpose method to be stability indicating, forced degradation studies were conducted and the method resolved the drug from its known impurities, stated above, and from additional impurities generated when POS subjected to forced degradation;the mass balance was found close to 100%. Regression analyses indicate correlation coefficient value greater than 0.999 for Posaconazole and its known impurities. The LOD for Posaconazole and the known impurities was at a level below 0.05%. The method has shown good, consistent recoveries for known impurities (89% - 106%). To summarise, the method was found to be accurate, precise, linear, specific, sensitive, rugged, robust, and stability-indicating. 展开更多
关键词 POSACONAZOLE Hydroxytriazole Tosylated Deshydroxy POSACONAZOLE Benzylated POSACONAZOLE STABILITY-INDICATING ICH Guidelines UPLC
暂未订购
Direct amination of pyrimidin-2-yl tosylates with aqueous ammonia under metal-free and mild conditions
11
作者 Hai-Peng Gong Yue Zhang +3 位作者 Yu-Xia Da Zhang Zhang Zheng-Jun Quan Xi-Cun Wang 《Chinese Chemical Letters》 SCIE CAS CSCD 2015年第6期667-671,共5页
A metal-flee synthesis of pyrimidine functionalized primary amines via direct amination of pyrimidin-2- yl tosylate with aqueous ammonia has been developed under mild conditions. The desired products pyrimidin-2-amine... A metal-flee synthesis of pyrimidine functionalized primary amines via direct amination of pyrimidin-2- yl tosylate with aqueous ammonia has been developed under mild conditions. The desired products pyrimidin-2-amines can be generated in excellent yields in PEG-400, without any catalysts or other additives. 展开更多
关键词 Ammonia 2-Aminopyrimidines Pyrimidin-2-yl tosylate PEG-400
原文传递
Highly efficient nickel/phosphine catalyzed cross-couplings of diarylborinic acids with aryl tosylates and sulfamates 被引量:1
12
作者 KE HaiHua CHEN XiaoFeng +1 位作者 FENG YuanYuan ZOU Gang 《Science China Chemistry》 SCIE EI CAS 2014年第8期1126-1131,共6页
Highly efficient cross-couplings of diarylborinic acids with aryl tosylates and sulfamates are reported for construction of biaryls using a tri(4-methoxyphenyl)phosphine-supported nickel catalyst system: Ni[P(4-MeOC6H... Highly efficient cross-couplings of diarylborinic acids with aryl tosylates and sulfamates are reported for construction of biaryls using a tri(4-methoxyphenyl)phosphine-supported nickel catalyst system: Ni[P(4-MeOC6H4)3]2Cl2/2P(4-MeOC6H4)3 in the presence of K3PO4·3H2O in toluene. A variety of unsymmetrical biaryls could be obtained in good to excellent yields with1.5–3 mol% or 3–5 mol% catalyst loadings for aryl sulfamates and tosylates, respectively. In sharp contrast to the conventional nickel-catalyzed Suzuki coupling with arylboronic acids, arylsulfamates unexpectedly displayed a higher reactivity than the corresponding tosylates in coupling with diarylborinic acids catalyzed by the nickel/phosphine catalyst system. 展开更多
关键词 NICKEL PHOSPHINE cross-coupling diarylborinic acid aryl tosylate aryl sulfamate
原文传递
Transition Metal Free Chemoselective Reduction ofα,β-Unsaturated Ketones to Saturated Ketones Using Tosyl Hydrazide as a Hydrogen Donor
13
作者 Yarabally R Girish Kanchipura R Raghavendra +2 位作者 Dasappa Nagaraja Kothanahally S Sharath Kumar Sheena Shashikanth 《Chinese Journal of Chemistry》 SCIE CAS CSCD 2015年第2期181-184,共4页
An efficient,inexpensive and simple method for the reduction of variousα,β-unsaturated ketones to corre-sponding saturated ketones using tosyl hydrazide as a hydrogen donor in DMF using calcium oxide powder has been... An efficient,inexpensive and simple method for the reduction of variousα,β-unsaturated ketones to corre-sponding saturated ketones using tosyl hydrazide as a hydrogen donor in DMF using calcium oxide powder has been reported.A variety of enones underwent reduction without forming undesirable side products.High chemose-lectivity,broad functional group tolerance and good yields are the noteworthy features of this protocol. 展开更多
关键词 α β-unsaturated carbonyl compounds tosyl hydrazide transition metal free saturated ketones
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部